NAV
$55.66
AUM
$505.4M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +4.03% | +3.16% | +5.30% | +9.61% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | IUGXX | Invesco Premier US Government Money Inst | 15.90% |
| 2 | ASML.AS | ASML Holding NV | 2.24% |
| 3 | HSBA.L | HSBC Holdings PLC | 1.15% |
| 4 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.05% |
| 5 | AZN.L | AstraZeneca PLC | 1.03% |
| 6 | NOVN.SW | Novartis AG Registered Shares | 1.02% |
| 7 | NESN.SW | Nestle SA | 0.93% |
| 8 | SHEL.L | Shell PLC | 0.86% |
| 9 | SIE.DE | Siemens AG | 0.85% |
| 10 | BHP.AX | BHP Group Ltd | 0.81% |
The fund seeks to achieve its investment objective by: (1) investing in a portfolio of equity securities, including depositary receipts, designed to track the performance, before fees and expenses, of the MSCI EAFE Index or U.S.-listed exchange-traded funds (ETFs) that seek to track the performance of the index, or both, and (2) utilizing an options-based income strategy implemented through equity-linked notes (ELNs) with exposure to either the index or ETFs tracking the index. The fund is non-diversified.
Inception Date: 2024-07-17